Regulatory & Legal

RVL Pharmaceuticals claims double-digit growth for its eye drop Upneeq, but as a private firm, its disruptive direct-to-consumer model operates outside public view.

As EyePoint's losses widen to fund its lead drug, DURAVYU, the company is on the cusp of pivotal trial results that could redefine retinal disease treatment.

With the hire of a Project Maven expert, the investment firm signals a major push to embed advanced AI into its middle-market defense companies.

Preclinical data for CITY-RBP4 shows promise in treating Stargardt disease, a leading cause of juvenile blindness with no approved therapies.

With a new $1B valuation, Nyobolt's ultra-fast charging tech aims to solve the critical energy bottleneck for autonomous robots and AI data centers.

Orthofix showcases its new FITBONE internal lengthening implant and AI-enhanced software, offering less invasive, more precise options for young patients.

Chicago's 2026/27 jazz lineup features Wynton Marsalis's final tour, a Coltrane centennial, and a celebration of the city's own musical heritage.

With a new $18M Series A, Scout Space is scaling its orbital sensor network and building a new Virginia facility to tackle growing risks in space.

A new report reveals 59% of firms made a "bad AI hire" last year. Discover the costly paradox and why traditional hiring methods are failing.

Boise's McMillen, Inc. wins the Grand Conceptor award for the world's largest dam removal, a project driven by Tribal leadership to restore a vital river.

New performance metrics have been proposed to reform a federal rule that threatens to decertify nearly half of U.S. organ procurement organizations.

The strategic hire of assurance veteran Andrew Palko signals Cohen & Co's push to deepen its fund audit expertise amid rising regulatory complexity.

Ontario's auto regulator doubled suspensions and recovered millions for buyers in 2025, signaling a tougher stance on dealer misconduct and illegal sales.

The U.S. Postal Service honors the 100th anniversary of Route 66 with new stamps, celebrating its history and aiming to fuel a modern tourism revival.

Private lender Arixa Capital surpasses $350M in Arizona financing, fueling a housing boom. But can this growth solve the state's affordability crisis?

A pioneering, fully uncrewed mission charts deep-sea corals, aiding environmental recovery and showcasing the future of maritime technology.

The largest-ever study on school phone bans confirms huge drops in phone use and improved student well-being, but the impact on test scores is more complex.

With a novel 'NewCo' model and key partnerships, Banyan BioInnovations aims to de-risk and accelerate clinical-stage drugs past the funding valley of death.

With new museums and unbeatable value, Memphis is evolving beyond its musical roots to become the must-visit U.S. city for 2026. Discover what's new.

Diagnostic leader Bracco enters the cell therapy market with BubbleGen, a novel microbubble tech that promises to streamline complex manufacturing.